Research carried out at Delta Dental of Michigan’s Research and Data Institute has suggested that oral cancer may be the most expensive form of cancer to treat.
According to new research, cancers of the oral cavity, pharynx and salivary glands may be the most costly forms of cancer to treat in the USA. The initial findings of the study will be discussed in detail in BioMed Central’s open access journal, which is called Head and Neck Oncology.
The research project was carried out in conjunction with Thomson Reuters, Vanderbilt University, Delta Dental of Wisconsin and the University of Illinois at Chicago College of Dentistry.
The project started in March 2010 and analysed claims data from patients with insurance provided by employers. On average, the total annual spending on healthcare during the 12 months after diagnosis was $79, 151, which was much higher than an average figure of $7,419 in a group of patients without those specific forms of cancer. Researchers also found that the cost of treatment was almost double when patients received chemotherapy, radiotherapy and surgical treatment.
Dr Jed Jacobsen, chief science officer at Delta Dental, said that the findings of the study indicate the cost faced by patients and the state for head and neck cancers.